Lattice Biologics Ltd. (TSXV: LBL)

Business Description

Lattice Biologics Ltd. (“Lattice”, “company”), based out of Scottsdale, Arizona, is an emerging player in the field of natural and regenerative tissue engineering for bone, skin, and cartilage, as well as novel products related to cancer diagnostics.

Website: http://www.latticebiologics.com/

FRC Analyst's Reports

Lattice Biologics (TSXV: LBL / OTCBB: BLVKF): Strengthens Pipeline	Sep. 7, 2016
Lattice Biologics (TSXV: LBL) New product sales growing	Jun. 6, 2016
Lattice Biologics (TSXV: LBL / OTCBB: BLVKF): Initiating; Regenerative Medicine	May. 11, 2016

News

Lattice Biologics Ltd. Reports Second Quarter 2021 Results and Resumes Trading	Jul. 9, 2021
IIROC Trading Halt – LBL	Jun. 7, 2021
Lattice Announces Strategic Advisory Board	Mar. 31, 2021
Lattice Announces Strategic Cannabis Supply Agreement With Firehouse	Mar. 19, 2021
Lattice Biologics Reorganizes to Focus on Psychedelics and Cannabis Therapies	Mar. 15, 2021